New and important changes in breast cancer TNM: incorporation of biologic factors into staging

References

• Dukes CE. The classification of cancer of the rectum. J Pathological Bacteriol. 1932;35:323.
   Google Scholar
• Denoix PF. Nomenclature and classification of cancers based on an atlas. Acta Union Int Contra Cancrum. 1953;9(4):769–771. PubMed PMID: 13138342.
   PubMedGoogle Scholar
• Amin MB, Edge SB, Greene F, et al., eds. AJCC cancer staging manual. 8th ed. Springer International Publishing AG Switzerland; 2017.
   Google Scholar
• Zheng Y, Walsh T, Gulsuner S, et al. Inherited breast cancer in Nigerian women. J Clin Oncol. 2018 Oct 1;36(28):2820–2825. PubMed PMID: 30130155.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. Springer International Publishing AG Switzerland; 2009.
   Google Scholar
• Plichta JK, Campbell BM, Mittendorf EA, et al. Anatomy and breast cancer staging: is it still relevant? Surg Oncol Clin N Am. 2018 Jan;27(1):51–67. PubMed PMID: 29132565.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 2010;12(4):207. PubMed PMID: 20804570; PubMed Central PMCID: PMCPMC2949637.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Viale G, Rotmensz N, et al. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Breast. 2006 Feb;15(1):3–8. PubMed PMID: 16473737.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Zurrida S, Viale G, et al. Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J. 2009 May–Jun;15(3):291–295. PubMed PMID: 19645785.
   PubMed Web of Science ®Google Scholar
• Yi M, Mittendorf EA, Cormier JN, et al. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American joint committee on cancer staging system. J Clin Oncol. 2011 Dec 10;29(35):4654–4661. PubMed PMID: 22084362; PubMed Central PMCID: PMCPMC3236648.
   PubMed Web of Science ®Google Scholar
• Mittendorf EA, Jeruss JS, Tucker SL, et al. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2011 May 20;29(15):1956–1962. PubMed PMID: 21482989; PubMed Central PMCID: PMCPMC3107758.
   PubMedGoogle Scholar
• Bagaria SP, Ray PS, Sim MS, et al. Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. JAMA Surg. 2014 Feb;149(2):125–129. PubMed PMID: 24306257.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN, Connolly JL, D’Orsi CJ, et al. Breast. In: Amin MB, Edge SB, Greene F, et al., editors. AJCC cancer staging manual. 8 ed. 2017.
   Google Scholar
• Mittendorf EA, Chavez-MacGregor M, Vila J, et al. Bioscore: a staging system for breast cancer patients that reflects the prognostic significance of underlying tumor biology. Ann Surg Oncol. 2017 Nov;24(12):3502–3509. PubMed PMID: 28726077; PubMed Central PMCID: PMCPMC5880531.
   PubMed Web of Science ®Google Scholar
• Bland KI, Menck HR, Scott-Conner CE, et al. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer. 1998 Sep 15;83(6):1262–1273. PubMed PMID: 9740094.
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989 Feb 23;320(8):479–484. PubMed PMID: 2644532.
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. PubMed PMID: 2644531.
   PubMed Web of Science ®Google Scholar
• Ludwig Breast Cancer Study G. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):491–496. PubMed PMID: 2644533.
   PubMed Web of Science ®Google Scholar
• Mansour EG, Gray R, Shatila AH, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. PubMed PMID: 2915651.
   PubMed Web of Science ®Google Scholar
• Breast Cancer Staging TNM8. [cited 2019 Feb 20]. Available from: https://itunes.apple.com/us/app/breast-cancer-staging-tnm-8/id1218852568
   Google Scholar
• Edge SB, McKellar D, Stewart AK. Using the American college of surgeons cancer registry to drive quality. J Oncol Pract. 2013 May;9(3):149–151. . PubMed PMID: 23942495; PubMed Central PMCID: PMCPMC3651564.
   PubMedGoogle Scholar
• Boffa DJ, Rosen JE, Mallin K, et al. Using the national cancer database for outcomes research: a review. JAMA Oncol. 2017 Dec 1;3(12):1722–1728. PubMed PMID: 28241198.
   PubMed Web of Science ®Google Scholar
• Plichta JK, Ren Y, Thomas SM, et al. Implications for breast cancer restaging based on the 8th edition AJCC staging manual. Ann Surg. 2018 Oct 11. DOI:10.1097/SLA.0000000000003071. PubMed PMID: 30312199.
   Google Scholar
• Full Revised Text of “Breast” in Amin MB, Edge SB, Greene F, et al. AJCC cancer staging manual. 8th ed. [cited 2019 Feb 20]. Available from: https://cancerstaging.org/references-tools/deskreferences/Pages/Breast-Cancer-Staging.aspx
   Google Scholar
• Hyams DM, Schuur E, Angel Aristizabal J, et al. Selecting postoperative adjuvant systemic therapy for early stage breast cancer: a critical assessment of commercially available gene expression assays. J Surg Oncol. 2017 May;115(6):647–662. PubMed PMID: 28211064; PubMed Central PMCID: PMCPMC5484338.
   PubMed Web of Science ®Google Scholar
• Sparano JA, Gray RJ, Makower DF, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med. 2015 Nov 19;373(21):2005–2014. PubMed PMID: 26412349; PubMed Central PMCID: PMCPMC4701034.
   PubMed Web of Science ®Google Scholar
• Cardoso F, van’t Veer LJ, Bogaerts J, et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med. 2016 Aug 25;375(8):717–729. PubMed PMID: 27557300.
   PubMed Web of Science ®Google Scholar
• Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018 Jul 12;379(2):111–121. PubMed PMID: 29860917; PubMed Central PMCID: PMCPMC6172658.
   PubMed Web of Science ®Google Scholar
• Broglio KR, Quintana M, Foster M, et al. Association of pathologic complete response to neoadjuvant therapy in HER2-positive breast cancer with long-term outcomes ameta-analysis. JAMA Oncol. 2016;2(6):571–760.
   Web of Science ®Google Scholar
• Houssami N, Macaskill P, von Minckwitz G, et al. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012 Dec;48(18):3342–3354. PubMed PMID: 22766518.
   PubMed Web of Science ®Google Scholar
• Weiss A, Chavez-MacGregor M, Lichtensztajn DY, et al. Validation study of the American joint committee on cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer. JAMA Oncol. 2018 Feb 1;4(2):203–209. PubMed PMID: 29222540; PubMed Central PMCID: PMCPMC5838705.
   PubMed Web of Science ®Google Scholar
• Wang M, Chen H, Wu K, et al. Evaluation of the prognostic stage in the 8th edition of the American joint committee on cancer in locally advanced breast cancer: an analysis based on SEER 18 database. Breast. 2018 Feb;37:56–63. PubMed PMID: 29100045.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting. Breast Cancer Res Treat. 2018 Feb;168(1):269–275. . PubMed PMID: 29143220.
   PubMed Web of Science ®Google Scholar
• Kurundkar A, Gao X, Zhang K, et al. Comparison of AJCC anatomic and clinical prognostic stage groups in breast cancer: analysis of 3322 cases from a single institution. Clin Breast Cancer. 2018 Jul 17. DOI:10.1016/j.clbc.2018.07.013. PubMed PMID: 30078612.
   PubMed Web of Science ®Google Scholar
• Kim I, Choi HJ, Ryu JM, et al. Prognostic validation of the American joint committee on cancer 8th staging system in 24,014 Korean patients with breast cancer. J Breast Cancer. 2018 Jun;21(2):173–181. PubMed PMID: 29963113; PubMed Central PMCID: PMCPMC6015977.
   PubMed Web of Science ®Google Scholar
• Ibis K, Ozkurt S, Kucucuk S, et al. Comparison of pathological prognostic stage and anatomic stage groups according to the updated version of the American Joint Committee on Cancer (AJCC) breast cancer staging 8th edition. Med Sci Monit. 2018 May 31;24:3637–3643. PubMed PMID: 29849016; PubMed Central PMCID: PMCPMC6007150.
   PubMed Web of Science ®Google Scholar
• Zombori T, Lehoczky L, Cserni B, et al. Evaluation of anatomic and prognostic stages of breast cancer according to the 8th edition of the TNM staging system - retrospective analysis based on data from deceased patients once diagnosed with breast cancer. Orv Hetil. 2017 Sep;158(35):1373–1381. PubMed PMID: 28847177.
   PubMed Web of Science ®Google Scholar
• Wong RX, Wong FY, Lim J, et al. Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting. Breast. 2018 Aug;40:38–44. PubMed PMID: 29677569.
   PubMed Web of Science ®Google Scholar
• Lee SB, Sohn G, Kim J, et al. A retrospective prognostic evaluation analysis using the 8th edition of the American joint committee on cancer staging system for breast cancer. Breast Cancer Res Treat. 2018 Jun;169(2):257–266. PubMed PMID: 29388016; PubMed Central PMCID: PMCPMC5945740.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lim JE, Jung HH, et al. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort. Breast Cancer Res Treat. 2018 Jun 21. DOI:10.1007/s10549-018-4858-z. PubMed PMID: 29931426.
   Web of Science ®Google Scholar
• Jang N, Choi JE, Kang SH, et al. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer. Virchows Arch. 2018 Nov 24. DOI:10.1007/s00428-018-2495-x. PubMed PMID: 30474738.
   Web of Science ®Google Scholar
• Ding J, Wu W, Fang J, et al. Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort. Int J Biol Markers. 2018 May;33(2):168–173. PubMed PMID: 28967067.
   PubMed Web of Science ®Google Scholar
• Zhou B, Xu L, Ye J, et al. The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in HER2-enriched subtype breast cancer, a retrospective analysis. Anticancer Res. 2017 Aug;37(8):4615–4621. PubMed PMID: 28739761.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang W, Xu L, et al. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer. Chin J Cancer Res. 2017 Aug;29(4):351–360. PubMed PMID: 28947867; PubMed Central PMCID: PMCPMC5592823.
   PubMed Web of Science ®Google Scholar
• Xu L, Li JH, Ye JM, et al. A retrospective survival analysis of anatomic and prognostic stage group based on the American joint committee on cancer 8th edition cancer staging manual in luminal b human epidermal growth factor receptor 2-negative breast cancer. Chin Med J ( Engl). 2017 Aug 20;130(16):1945–1952. PubMed PMID: 28776547; PubMed Central PMCID: PMCPMC5555129.
   PubMed Web of Science ®Google Scholar
• Hu H, Wei W, Yi X, et al. A retrospective analysis of clinical utility of AJCC 8th edition cancer staging system for breast cancer. World J Oncol. 2017 Jun;8(3):71–75. PubMed PMID: 29147438; PubMed Central PMCID: PMCPMC5650000.
   PubMedGoogle Scholar
• Joo JH, Kim SS, Son BH, et al. Evaluation of the prognostic stage in the 8th edition of the American joint committee on cancer in patients with breast cancer and internal mammary lymph node metastasis. Anticancer Res. 2018 Sep;38(9):5357–5361. PubMed PMID: 30194189.
   PubMed Web of Science ®Google Scholar
• O’Cearbhaill R, Gannon JM, Prichard RS, et al. The American joint commission cancer 8th edition prognostic stage including oncotype DX(R) recurrence score: impact on staging of early breast cancer. Pathobiology. 2018 Oct 22:1–6. PubMed PMID: 30347405. DOI:10.1159/000493363
   PubMedGoogle Scholar
• Breaux A, Turner B, Wu X, et al. Impact of 21-gene expression assay on staging estrogen receptor-positive HER2-negative breast cancer. Clin Breast Cancer. 2018 Oct 29. DOI:10.1016/j.clbc.2018.10.005. PubMed PMID: 30509870.
   PubMed Web of Science ®Google Scholar
• Quinn C, Rakha EA. Eighth edition cancer staging manual of breast cancer by the American joint committee on cancer: are the new changes to improve staging or a treatment decision tool? J Clin Pathol. 2018 Jul 26. DOI:10.1136/jclinpath-2018-205255. PubMed PMID: 30049817.
   Web of Science ®Google Scholar
• Standards for Oncology Registry Entry (STORE Manual) 2018. [cited 2019 Feb 20]. Available from: https://www.facs.org/quality-programs/cancer/ncdb/registrymanuals/cocmanuals
   Google Scholar
• TNM8 Breast Cancer Staging. [cited 2019 Feb 20]. Available from: https://play.google.com/store/apps/details?id=com.roche.latam.tnm8
   Google Scholar
• Dietze EC, Sistrunk C, Miranda-Carboni G, et al. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015 Apr;15(4):248–254. PubMed PMID: 25673085; PubMed Central PMCID: PMCPMC5470637.
   PubMed Web of Science ®Google Scholar
• Newman LA. Disparities in breast cancer and african ancestry: a global perspective. Breast J. 2015 Mar–Apr;21(2):133–139. PubMed PMID: 25639288.
   PubMed Web of Science ®Google Scholar
• Mallin K, Palis BE, Watroba N, et al. Completeness of American cancer registry treatment data: implications for quality of care research. J Am Coll Surg. 2013 Mar;216(3):428–437. PubMed PMID: 23357724.
   PubMed Web of Science ®Google Scholar
• Chung AP, Huynh K, Kidner T, et al. Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. J Am Coll Surg. 2012 Jul;215(1):137–46; discussion 146–7. PubMed PMID: 22608402.
   PubMed Web of Science ®Google Scholar
• Vera-Badillo FE, Napoleone M, Ocana A, et al. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014 Jul;146(2):235–244. PubMed PMID: 24928527.
   PubMed Web of Science ®Google Scholar
• Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol. 2012 Dec;23(12):3063–3069. PubMed PMID: 22776706; PubMed Central PMCID: PMCPMC3501230.
   PubMed Web of Science ®Google Scholar
• Bossuyt V, Provenzano E, Symmans WF, et al. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol. 2015 Jul;26(7):1280–1291. PubMed PMID: 26019189; PubMed Central PMCID: PMCPMC4804123.
   PubMed Web of Science ®Google Scholar
• Bergquist JR, Murphy BL, Storlie CB, et al. Incorporation of treatment response, tumor grade and receptor status improves staging quality in breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2017 Nov;24(12):3510–3517. PubMed PMID: 28828583.
   PubMed Web of Science ®Google Scholar
• Lai J, Wang H, Peng J, et al. Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy. Cancer Manag Res. 2018;10:2347–2356. PubMed PMID: 30122984; PubMed Central PMCID: PMCPMC6078091.
   PubMed Web of Science ®Google Scholar
• Mittendorf EA, Vila J, Tucker SL, et al. The neo-bioscore update for staging breast cancer treated with neoadjuvant chemotherapy: incorporation of prognostic biologic factors into staging after treatment. JAMA Oncol. 2016 Jul 1;2(7):929–936. PubMed PMID: 26986538; PubMed Central PMCID: PMCPMC5757376.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Meisel J, et al. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National cancer database. Breast Cancer Res Treat. 2018 Sep;171(2):303–313. PubMed PMID: 29948405.
   PubMed Web of Science ®Google Scholar
• Compton C. Precision medicine core: progress in prognostication-populations to patients. Ann Surg Oncol. 2018 Feb;25(2):349–350. PubMed PMID: 28801842.
   PubMed Web of Science ®Google Scholar